Journal
CHEMMEDCHEM
Volume 1, Issue 7, Pages 706-+Publisher
WILEY-V C H VERLAG GMBH
DOI: 10.1002/cmdc.200600031
Keywords
-
Categories
Ask authors/readers for more resources
The discovery of UK-374,503 started from a high-throughput screening hit that was a potent Type II P450 2D6 inhibitor and which displayed no antiviral activity. The optimisation of affinity for the CCR5 receptor while reducing concerns about P450 inhibition and the subsequent introduction of antiviral effects were key milestones for the project.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available